ARTICLE | Company News
CSL gains exclusive rights to Cevec's CAPGo technology
May 18, 2018 7:12 PM UTC
Cevec Pharmaceuticals GmbH (Cologne, Germany) granted CSL Ltd. (ASX:CSL) exclusive rights to develop and commercialize CAPGo-derived complement 1 (C1) esterase inhibitor proteins for hereditary angioedema (HAE)...